FBT

First Trust NYSE Arca Biotech ETF

About FBT

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology IndexSM. The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.

Buy US stocks in Australia starting with FBT. Open an account and start investing today!

Market Capitalisation

Price-earnings ratio

Dividend yield

1.46%

Volume

25.61K

High today

$152.37

Low today

$150.82

Open price

$152.02

52-week high

$166.00

52-week low

$121.68

FBT FAQs

How much is one share of First Trust NYSE Arca Biotech ETF?

One share of First Trust NYSE Arca Biotech ETF is valued at $151.69.

What is the ticker symbol for First Trust NYSE Arca Biotech ETF?

The ticker symbol for First Trust NYSE Arca Biotech ETF is FBT.

How do I buy FBT shares in Australia?

To buy FBT stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in FBT

What is the 52-week high for First Trust NYSE Arca Biotech ETF stock?

The First Trust NYSE Arca Biotech ETF 52-week high stock price is $166.00.

What is the 52-week low for First Trust NYSE Arca Biotech ETF stock?

The First Trust NYSE Arca Biotech ETF 52-week low stock price is $121.68.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.